ZELTIQ Aesthetics developed and commercialized the CoolSculpting system, a medical device platform using controlled cooling (cryolipolysis) for non-invasive fat reduction and body contouring
ZELTIQ Aesthetics developed and commercialized the CoolSculpting system, a medical device platform using controlled cooling (cryolipolysis) for non-invasive fat reduction and body contouring. Founded in 2005, it was acquired by Allergan in 2017; Allergan is now part of AbbVie.